Toll Free: 1-888-928-9744

Universal Biosensors, Inc. (UBI) - Product Pipeline Analysis, 2016 Update

Published: Jun 15, 2016 | Pages: 29 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Universal Biosensors, Inc. (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. UBI's major focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. Its in vitro diagnostic test devices are based on electrochemical cell technology platform. The company manages its research and development, and manufacturing operations through its subsidiary, Universal Biosensors Pty Ltd (UBS) in Melbourne. UBI is headquartered in Melbourne, Victoria, Australia. 

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Universal Biosensors, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Universal Biosensors, Inc. Company Snapshot 5 Universal Biosensors, Inc. Company Overview 5 Universal Biosensors, Inc. Pipeline Products and Clinical Trials Overview 6 Universal Biosensors, Inc. - Pipeline Analysis Overview 8 Business Description 8 Key Facts 8 Universal Biosensors, Inc. - Major Products and Services 9 Universal Biosensors, Inc. Pipeline Products by Development Stage 10 Universal Biosensors, Inc. Pipeline Products Overview 12 C-Reactive Protein Test 12 C-Reactive Protein Test Product Overview 12 Diagnostic Assay - Coagulation 13 Diagnostic Assay - Coagulation Product Overview 13 DNA/RNA Blood Glucose Test 14 DNA/RNA Blood Glucose Test Product Overview 14 Handheld POC Coagulation Testing System - Ambulatory Care 15 Handheld POC Coagulation Testing System - Ambulatory Care Product Overview 15 Immunoassay Test - D-Dimer 16 Immunoassay Test - D-Dimer Product Overview 16 PT-INR Testing System - Decentralised And Home Use 17 PT-INR Testing System - Decentralised And Home Use Product Overview 17 Universal Biosensors, Inc. - Key Competitors 18 Universal Biosensors, Inc. - Key Employees 19 Universal Biosensors, Inc. - Key Employee Biographies 20 Universal Biosensors, Inc. - Locations And Subsidiaries 21 Head Office 21 Other Locations & Subsidiaries 21 Recent Developments 22 Universal Biosensors, Inc., Recent Developments 22 Mar 02, 2016: Universal Biosensors Appoints David Hoey as Non-Executive Director 22 Oct 15, 2015: Development Update: UBI PT-INR Testing System for decentralised and home use 22 Jul 23, 2015: Half Yearly Report and SEC Form 10Q for Q2 2015 23 May 13, 2015: Siemens Healthcare Diagnostics launches Xprecia Stride Coagulation Analyzer 23 Dec 17, 2014: Launch of Siemens Xprecia Stride Coagulation Analyzer for the point-of-care 24 Dec 09, 2014: Blood coagulation testing system approved for the European market 24 Sep 17, 2014: Delay to launch of new PT-INR testing system 25 Jul 24, 2014: Universal Biosensors reports total revenues of AUD2.9m in H1 2014 25 Feb 14, 2014: Universal Biosensors Announces FY2013 Financial Results 27 Oct 08, 2013: UBI Business Update 27 Appendix 29 Methodology 29 About GlobalData 29 Contact Us 29 Disclaimer 29
List of Tables
Universal Biosensors, Inc. Pipeline Products and Clinical Trials Overview 6 Universal Biosensors, Inc. Pipeline Products by Equipment Type 6 Universal Biosensors, Inc. Pipeline Products by Indication 7 Universal Biosensors, Inc., Key Facts 8 Universal Biosensors, Inc., Major Products and Services 9 Universal Biosensors, Inc. Number of Pipeline Products by Development Stage 10 Universal Biosensors, Inc. Pipeline Products Summary by Development Stage 11 C-Reactive Protein Test - Product Status 12 C-Reactive Protein Test - Product Description 12 Diagnostic Assay - Coagulation - Product Status 13 Diagnostic Assay - Coagulation - Product Description 13 DNA/RNA Blood Glucose Test - Product Status 14 DNA/RNA Blood Glucose Test - Product Description 14 Handheld POC Coagulation Testing System - Ambulatory Care - Product Status 15 Handheld POC Coagulation Testing System - Ambulatory Care - Product Description 15 Immunoassay Test - D-Dimer - Product Status 16 Immunoassay Test - D-Dimer - Product Description 16 PT-INR Testing System - Decentralised And Home Use - Product Status 17 PT-INR Testing System - Decentralised And Home Use - Product Description 17 Universal Biosensors, Inc., Key Employees 19 Universal Biosensors, Inc., Key Employee Biographies 20 Universal Biosensors, Inc., Subsidiaries 21


List of Figures
Universal Biosensors, Inc. Pipeline Products by Equipment Type 7 Universal Biosensors, Inc. Pipeline Products by Development Stage 10

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the i

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify